Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
Marofi F, Tahmasebi S, Rahman HS, Kaigorodov D, Markov A, Yumashev AV, Shomali N, Chartrand MS, Pathak Y, Mohammed RN, Jarahian M, Motavalli R, Motavalli Khiavi F. Marofi F, et al. Among authors: mohammed rn. Stem Cell Res Ther. 2021 Mar 29;12(1):217. doi: 10.1186/s13287-021-02283-z. Stem Cell Res Ther. 2021. PMID: 33781320 Free PMC article. Review.
Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy.
Marofi F, Rahman HS, Thangavelu L, Dorofeev A, Bayas-Morejón F, Shirafkan N, Shomali N, Chartrand MS, Jarahian M, Vahedi G, Mohammed RN, Shahrokh S, Akbari M, Khiavi FM. Marofi F, et al. Among authors: mohammed rn. Stem Cell Res Ther. 2021 Mar 22;12(1):200. doi: 10.1186/s13287-021-02251-7. Stem Cell Res Ther. 2021. PMID: 33752707 Free PMC article. Review.
Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
Marofi F, Tahmasebi S, Rahman HS, Kaigorodov D, Markov A, Yumashev AV, Shomali N, Chartrand MS, Pathak Y, Mohammed RN, Jarahian M, Motavalli R, Khiavi FM. Marofi F, et al. Among authors: mohammed rn. Stem Cell Res Ther. 2021 Aug 6;12(1):443. doi: 10.1186/s13287-021-02523-2. Stem Cell Res Ther. 2021. PMID: 34362452 Free PMC article. No abstract available.
Under hypoxic conditions, MSCs affect the expression and methylation level of survival-related genes in ALL independent of apoptosis pathways in vitro.
Marofi F, Shomali N, Younus LA, Hassanzadeh A, Vahedi G, Kuznetsova MY, Solali S, Gharibi T, Hosseini A, Mohammed RN, Mohammadi H, Tamjidifar R, Firouzi-Amandi A, Farshdousti Hagh M. Marofi F, et al. Among authors: mohammed rn. Biotechnol Appl Biochem. 2022 Apr;69(2):822-839. doi: 10.1002/bab.2154. Epub 2021 May 2. Biotechnol Appl Biochem. 2022. PMID: 33786874
Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction.
Mardi A, Shirokova AV, Mohammed RN, Keshavarz A, Zekiy AO, Thangavelu L, Mohamad TAM, Marofi F, Shomali N, Zamani A, Akbari M. Mardi A, et al. Among authors: mohammed rn. Cancer Cell Int. 2022 Apr 29;22(1):168. doi: 10.1186/s12935-022-02585-z. Cancer Cell Int. 2022. PMID: 35488303 Free PMC article. Review.
Correction to: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19).
Mohammed RN, Tamjidifar R, Rahman HS, Adili A, Ghoreishizadeh S, Saeedi H, Thangavelu L, Shomali N, Aslaminabad R, Marofi F, Tahavvori M, Danishna S, Akbari M, Ercan G. Mohammed RN, et al. Cell Commun Signal. 2022 Jun 15;20(1):90. doi: 10.1186/s12964-022-00913-4. Cell Commun Signal. 2022. PMID: 35705949 Free PMC article. No abstract available.
36 results